Do second generation sequencing techniques identify documented genetic markers for neonatal diabetes mellitus?

Area of Science:

• Genetics
• Pediatrics
• Molecular Biology

Background:

• Neonatal diabetes mellitus (NDM) is a rare, heterogeneous genetic disorder in infants caused by single-gene mutations.
• Mutations in KCNJ11 and ABCC8 genes, encoding voltage-dependent potassium channel subunits, are common causes of NDM.
• Traditional DNA-Sanger sequencing has limitations in screening large genomic regions.

Purpose of the Study:

• To evaluate the efficacy of second-generation sequencing techniques in detecting previously identified NDM-associated genetic variations.
• To compare the capabilities of next-generation sequencing (NGS) applications, including whole exome sequencing (WES) and whole genome sequencing (WGS), with Sanger sequencing for NDM diagnosis.

Main Methods:

• Review of global studies utilizing NGS, including WES, WGS, and targeted gene panels, for NDM genetic analysis.
• Cross-checking of variants identified by Sanger sequencing with those detected by second-generation sequencing methods.

Main Results:

• Whole exome sequencing (WES) successfully confirmed previously documented NDM variants identified by Sanger sequencing.
• Whole genome sequencing (WGS) proved to be the most comprehensive method, verifying known variants and identifying novel enhancers.
• Second-generation sequencing techniques offer rapid and economical alternatives to Sanger sequencing for NDM diagnosis.

Conclusions:

• WES is a powerful tool for verifying NDM-associated variants.
• WGS provides the most comprehensive genetic analysis for NDM, detecting both known and novel variants.
• Future NDM research should employ second-generation sequencing techniques for comprehensive genetic screening in affected children.